Tomoyuki Sugimoto

Author PubWeight™ 17.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer 2011 2.97
2 Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables. Biom J 2012 2.06
3 Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomy. Surgery 2009 1.60
4 Sample size determination in clinical trials with multiple co-primary binary endpoints. Stat Med 2010 1.02
5 Sample size determination for clinical trials with co-primary outcomes: exponential event times. Pharm Stat 2012 1.00
6 Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints. J Biopharm Stat 2011 0.97
7 Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis. J Neuroinflammation 2011 0.92
8 Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosis. J Immunol 2012 0.89
9 The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells. PLoS One 2011 0.88
10 Sample size determination in group-sequential clinical trials with two co-primary endpoints. Stat Med 2014 0.85
11 Relationship between catheter care and catheter-associated urinary tract infection at Japanese general hospitals: a prospective observational study. Int J Nurs Stud 2006 0.79
12 Regional differences in population-based cancer survival between six prefectures in Japan: application of relative survival models with funnel plots. Cancer Sci 2009 0.78
13 Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorder. BMC Med Res Methodol 2010 0.78
14 Trends in 'cure' fraction from colorectal cancer by age and tumour stage between 1975 and 2000, using population-based data, Osaka, Japan. Jpn J Clin Oncol 2012 0.77
15 Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis. J Neuroinflammation 2014 0.77
16 Authors' reply. Biom J 2013 0.75
17 Role of age and tumour stage in the temporal pattern of 'cure' from stomach cancer: a population-based study in Osaka, Japan. Cancer Epidemiol 2012 0.75